CMAP amplitude differences did not reach statistical significance in SA4503 treated group compared with untreated mice at the end of the follow up.
← all excerpts
Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1<sup>G93A</sup> ALS Mice.
1
—
—